The Generation of Monoclonal Antibodies against Human Peroxisome Proliferator-activated Receptors (PPARs)

Monoclonal antibodies (Mabs) are valuable reagents for the purification, characterization and immunolocalization of proteins. In this study, we raised Mabs against human peroxisome proliferator-activated receptors (PPARs) using baculovirus particles displaying surface glycoprotein gp64-fusion protei...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Atherosclerosis and Thrombosis 2002, Vol.9(5), pp.233-242
Hauptverfasser: Tanaka, Toshiya, Takeno, Tetsu, Watanabe, Yuichiro, Uchiyama, Yasutoshi, Murakami, Takeshi, Yamashita, Hisahiko, Suzuki, Akifumi, Aoi, Rie, Iwanari, Hiroko, Jiang, Shu-Ying, Naito, Makoto, Tachibana, Keisuke, Doi, Takefumi, Shulman, Andrew I., Mangelsdorf, David J., Reiter, Raphael, Auwerx, Johan, Hamakubo, Takao, Kodama, Tatsuhiko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 242
container_issue 5
container_start_page 233
container_title Journal of Atherosclerosis and Thrombosis
container_volume 9
creator Tanaka, Toshiya
Takeno, Tetsu
Watanabe, Yuichiro
Uchiyama, Yasutoshi
Murakami, Takeshi
Yamashita, Hisahiko
Suzuki, Akifumi
Aoi, Rie
Iwanari, Hiroko
Jiang, Shu-Ying
Naito, Makoto
Tachibana, Keisuke
Doi, Takefumi
Shulman, Andrew I.
Mangelsdorf, David J.
Reiter, Raphael
Auwerx, Johan
Hamakubo, Takao
Kodama, Tatsuhiko
description Monoclonal antibodies (Mabs) are valuable reagents for the purification, characterization and immunolocalization of proteins. In this study, we raised Mabs against human peroxisome proliferator-activated receptors (PPARs) using baculovirus particles displaying surface glycoprotein gp64-fusion proteins as the immunizing agent. In this system, to display fusion proteins on the viral surface, the amino terminal sequences of human PPARδ and PPARγ2 are inserted in-frame between the signal sequence and the mature domain of the gp64 nucleotide sequence. Mabs were raised by immunization with whole virus without a purification of the target antigens. The Mabs generated by this novel method were shown to recognize not only the gp64-PPARs fusion protein, but also mature, expressed proteins by a wide variety of techniques, including immunohistochemistry, immunoblotting, and electrophoretic mobility shift assays (EMSAs). Transfection of the transfer vector containing a nucleotide sequence encoding less than 30 amino acids along with linearized baculovirus DNA allows for the production of a high affinity antibody against the corresponding mature form. This method is of potential utility in that it allows the production of valuable antibodies without the requirement of a protein purification step.
doi_str_mv 10.5551/jat.9.233
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04151318v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72644260</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5103-42c42bc57d47447f9a3b790598c7f6518397b79d500e8290c051fdb6f64b5c843</originalsourceid><addsrcrecordid>eNpFkc1uGyEURlHVqvlpF32BilXVLMaFAQZm0YUVpXElR7GidI0Y5k6MNQMu4Kh5--LYchZXXH069yz4EPpCyUwIQX9sTJ61s5qxd-icKkUqpiR7X3bGy86lOkMXKW0IYUyI-iM6ozUnbcPYOXKPa8C34CGa7ILHYcB3wQc7Bm9GPPfZdaF3kLB5Ms6njBe7yXi8ghj-uRQmwKsYRjfs70OsjM3u2WTo8QNY2JYo4e-r1fwhXX1CHwYzJvh8fC_Rn183j9eLanl_-_t6vqysoIRVvLa87qyQPZecy6E1rJMtEa2ycmgEVayVJegFIaDqllgi6NB3zdDwTljF2SW6OnjXZtTb6CYTX3QwTi_mS73PCKeCMqqeaWG_HdhtDH93kLKeXLIwjsZD2CUt64bzuiFvUhtDShGGk5kSve9Alw50q0sHhf16lO66Cfo38vjpBfh5ADYpmyc4ASZmZ0c4qsTrFOEpt2sTNXj2HwFel04</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72644260</pqid></control><display><type>article</type><title>The Generation of Monoclonal Antibodies against Human Peroxisome Proliferator-activated Receptors (PPARs)</title><source>MEDLINE</source><source>J-STAGE (Japan Science &amp; Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Tanaka, Toshiya ; Takeno, Tetsu ; Watanabe, Yuichiro ; Uchiyama, Yasutoshi ; Murakami, Takeshi ; Yamashita, Hisahiko ; Suzuki, Akifumi ; Aoi, Rie ; Iwanari, Hiroko ; Jiang, Shu-Ying ; Naito, Makoto ; Tachibana, Keisuke ; Doi, Takefumi ; Shulman, Andrew I. ; Mangelsdorf, David J. ; Reiter, Raphael ; Auwerx, Johan ; Hamakubo, Takao ; Kodama, Tatsuhiko</creator><creatorcontrib>Tanaka, Toshiya ; Takeno, Tetsu ; Watanabe, Yuichiro ; Uchiyama, Yasutoshi ; Murakami, Takeshi ; Yamashita, Hisahiko ; Suzuki, Akifumi ; Aoi, Rie ; Iwanari, Hiroko ; Jiang, Shu-Ying ; Naito, Makoto ; Tachibana, Keisuke ; Doi, Takefumi ; Shulman, Andrew I. ; Mangelsdorf, David J. ; Reiter, Raphael ; Auwerx, Johan ; Hamakubo, Takao ; Kodama, Tatsuhiko</creatorcontrib><description>Monoclonal antibodies (Mabs) are valuable reagents for the purification, characterization and immunolocalization of proteins. In this study, we raised Mabs against human peroxisome proliferator-activated receptors (PPARs) using baculovirus particles displaying surface glycoprotein gp64-fusion proteins as the immunizing agent. In this system, to display fusion proteins on the viral surface, the amino terminal sequences of human PPARδ and PPARγ2 are inserted in-frame between the signal sequence and the mature domain of the gp64 nucleotide sequence. Mabs were raised by immunization with whole virus without a purification of the target antigens. The Mabs generated by this novel method were shown to recognize not only the gp64-PPARs fusion protein, but also mature, expressed proteins by a wide variety of techniques, including immunohistochemistry, immunoblotting, and electrophoretic mobility shift assays (EMSAs). Transfection of the transfer vector containing a nucleotide sequence encoding less than 30 amino acids along with linearized baculovirus DNA allows for the production of a high affinity antibody against the corresponding mature form. This method is of potential utility in that it allows the production of valuable antibodies without the requirement of a protein purification step.</description><identifier>ISSN: 1340-3478</identifier><identifier>EISSN: 1880-3873</identifier><identifier>DOI: 10.5551/jat.9.233</identifier><identifier>PMID: 12409633</identifier><language>eng</language><publisher>Japan: Japan Atherosclerosis Society</publisher><subject>Animals ; Antibodies, Monoclonal - genetics ; Antibodies, Monoclonal - immunology ; Baculovirus ; Blotting, Western ; CHO Cells ; Cricetinae ; Electrophoretic Mobility Shift Assay ; Enzyme-Linked Immunosorbent Assay ; Female ; Gp64-fusion protein ; Humans ; Immunohistochemistry ; Life Sciences ; Mice ; Mice, Inbred BALB C ; Monoclonal antibody (Mab) ; Nucleopolyhedrovirus - genetics ; Peroxisome proliferator-activated receptors (PPARs) ; Receptors, Cytoplasmic and Nuclear - immunology ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - immunology ; Spodoptera ; Transcription Factors - immunology</subject><ispartof>Journal of Atherosclerosis and Thrombosis, 2002, Vol.9(5), pp.233-242</ispartof><rights>2002 Japan Atherosclerosis Society</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5103-42c42bc57d47447f9a3b790598c7f6518397b79d500e8290c051fdb6f64b5c843</citedby><cites>FETCH-LOGICAL-c5103-42c42bc57d47447f9a3b790598c7f6518397b79d500e8290c051fdb6f64b5c843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,1883,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12409633$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04151318$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Tanaka, Toshiya</creatorcontrib><creatorcontrib>Takeno, Tetsu</creatorcontrib><creatorcontrib>Watanabe, Yuichiro</creatorcontrib><creatorcontrib>Uchiyama, Yasutoshi</creatorcontrib><creatorcontrib>Murakami, Takeshi</creatorcontrib><creatorcontrib>Yamashita, Hisahiko</creatorcontrib><creatorcontrib>Suzuki, Akifumi</creatorcontrib><creatorcontrib>Aoi, Rie</creatorcontrib><creatorcontrib>Iwanari, Hiroko</creatorcontrib><creatorcontrib>Jiang, Shu-Ying</creatorcontrib><creatorcontrib>Naito, Makoto</creatorcontrib><creatorcontrib>Tachibana, Keisuke</creatorcontrib><creatorcontrib>Doi, Takefumi</creatorcontrib><creatorcontrib>Shulman, Andrew I.</creatorcontrib><creatorcontrib>Mangelsdorf, David J.</creatorcontrib><creatorcontrib>Reiter, Raphael</creatorcontrib><creatorcontrib>Auwerx, Johan</creatorcontrib><creatorcontrib>Hamakubo, Takao</creatorcontrib><creatorcontrib>Kodama, Tatsuhiko</creatorcontrib><title>The Generation of Monoclonal Antibodies against Human Peroxisome Proliferator-activated Receptors (PPARs)</title><title>Journal of Atherosclerosis and Thrombosis</title><addtitle>JAT</addtitle><description>Monoclonal antibodies (Mabs) are valuable reagents for the purification, characterization and immunolocalization of proteins. In this study, we raised Mabs against human peroxisome proliferator-activated receptors (PPARs) using baculovirus particles displaying surface glycoprotein gp64-fusion proteins as the immunizing agent. In this system, to display fusion proteins on the viral surface, the amino terminal sequences of human PPARδ and PPARγ2 are inserted in-frame between the signal sequence and the mature domain of the gp64 nucleotide sequence. Mabs were raised by immunization with whole virus without a purification of the target antigens. The Mabs generated by this novel method were shown to recognize not only the gp64-PPARs fusion protein, but also mature, expressed proteins by a wide variety of techniques, including immunohistochemistry, immunoblotting, and electrophoretic mobility shift assays (EMSAs). Transfection of the transfer vector containing a nucleotide sequence encoding less than 30 amino acids along with linearized baculovirus DNA allows for the production of a high affinity antibody against the corresponding mature form. This method is of potential utility in that it allows the production of valuable antibodies without the requirement of a protein purification step.</description><subject>Animals</subject><subject>Antibodies, Monoclonal - genetics</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Baculovirus</subject><subject>Blotting, Western</subject><subject>CHO Cells</subject><subject>Cricetinae</subject><subject>Electrophoretic Mobility Shift Assay</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Gp64-fusion protein</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Life Sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Monoclonal antibody (Mab)</subject><subject>Nucleopolyhedrovirus - genetics</subject><subject>Peroxisome proliferator-activated receptors (PPARs)</subject><subject>Receptors, Cytoplasmic and Nuclear - immunology</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - immunology</subject><subject>Spodoptera</subject><subject>Transcription Factors - immunology</subject><issn>1340-3478</issn><issn>1880-3873</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc1uGyEURlHVqvlpF32BilXVLMaFAQZm0YUVpXElR7GidI0Y5k6MNQMu4Kh5--LYchZXXH069yz4EPpCyUwIQX9sTJ61s5qxd-icKkUqpiR7X3bGy86lOkMXKW0IYUyI-iM6ozUnbcPYOXKPa8C34CGa7ILHYcB3wQc7Bm9GPPfZdaF3kLB5Ms6njBe7yXi8ghj-uRQmwKsYRjfs70OsjM3u2WTo8QNY2JYo4e-r1fwhXX1CHwYzJvh8fC_Rn183j9eLanl_-_t6vqysoIRVvLa87qyQPZecy6E1rJMtEa2ycmgEVayVJegFIaDqllgi6NB3zdDwTljF2SW6OnjXZtTb6CYTX3QwTi_mS73PCKeCMqqeaWG_HdhtDH93kLKeXLIwjsZD2CUt64bzuiFvUhtDShGGk5kSve9Alw50q0sHhf16lO66Cfo38vjpBfh5ADYpmyc4ASZmZ0c4qsTrFOEpt2sTNXj2HwFel04</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Tanaka, Toshiya</creator><creator>Takeno, Tetsu</creator><creator>Watanabe, Yuichiro</creator><creator>Uchiyama, Yasutoshi</creator><creator>Murakami, Takeshi</creator><creator>Yamashita, Hisahiko</creator><creator>Suzuki, Akifumi</creator><creator>Aoi, Rie</creator><creator>Iwanari, Hiroko</creator><creator>Jiang, Shu-Ying</creator><creator>Naito, Makoto</creator><creator>Tachibana, Keisuke</creator><creator>Doi, Takefumi</creator><creator>Shulman, Andrew I.</creator><creator>Mangelsdorf, David J.</creator><creator>Reiter, Raphael</creator><creator>Auwerx, Johan</creator><creator>Hamakubo, Takao</creator><creator>Kodama, Tatsuhiko</creator><general>Japan Atherosclerosis Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope></search><sort><creationdate>2002</creationdate><title>The Generation of Monoclonal Antibodies against Human Peroxisome Proliferator-activated Receptors (PPARs)</title><author>Tanaka, Toshiya ; Takeno, Tetsu ; Watanabe, Yuichiro ; Uchiyama, Yasutoshi ; Murakami, Takeshi ; Yamashita, Hisahiko ; Suzuki, Akifumi ; Aoi, Rie ; Iwanari, Hiroko ; Jiang, Shu-Ying ; Naito, Makoto ; Tachibana, Keisuke ; Doi, Takefumi ; Shulman, Andrew I. ; Mangelsdorf, David J. ; Reiter, Raphael ; Auwerx, Johan ; Hamakubo, Takao ; Kodama, Tatsuhiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5103-42c42bc57d47447f9a3b790598c7f6518397b79d500e8290c051fdb6f64b5c843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal - genetics</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Baculovirus</topic><topic>Blotting, Western</topic><topic>CHO Cells</topic><topic>Cricetinae</topic><topic>Electrophoretic Mobility Shift Assay</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Gp64-fusion protein</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Life Sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Monoclonal antibody (Mab)</topic><topic>Nucleopolyhedrovirus - genetics</topic><topic>Peroxisome proliferator-activated receptors (PPARs)</topic><topic>Receptors, Cytoplasmic and Nuclear - immunology</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - immunology</topic><topic>Spodoptera</topic><topic>Transcription Factors - immunology</topic><toplevel>online_resources</toplevel><creatorcontrib>Tanaka, Toshiya</creatorcontrib><creatorcontrib>Takeno, Tetsu</creatorcontrib><creatorcontrib>Watanabe, Yuichiro</creatorcontrib><creatorcontrib>Uchiyama, Yasutoshi</creatorcontrib><creatorcontrib>Murakami, Takeshi</creatorcontrib><creatorcontrib>Yamashita, Hisahiko</creatorcontrib><creatorcontrib>Suzuki, Akifumi</creatorcontrib><creatorcontrib>Aoi, Rie</creatorcontrib><creatorcontrib>Iwanari, Hiroko</creatorcontrib><creatorcontrib>Jiang, Shu-Ying</creatorcontrib><creatorcontrib>Naito, Makoto</creatorcontrib><creatorcontrib>Tachibana, Keisuke</creatorcontrib><creatorcontrib>Doi, Takefumi</creatorcontrib><creatorcontrib>Shulman, Andrew I.</creatorcontrib><creatorcontrib>Mangelsdorf, David J.</creatorcontrib><creatorcontrib>Reiter, Raphael</creatorcontrib><creatorcontrib>Auwerx, Johan</creatorcontrib><creatorcontrib>Hamakubo, Takao</creatorcontrib><creatorcontrib>Kodama, Tatsuhiko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of Atherosclerosis and Thrombosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanaka, Toshiya</au><au>Takeno, Tetsu</au><au>Watanabe, Yuichiro</au><au>Uchiyama, Yasutoshi</au><au>Murakami, Takeshi</au><au>Yamashita, Hisahiko</au><au>Suzuki, Akifumi</au><au>Aoi, Rie</au><au>Iwanari, Hiroko</au><au>Jiang, Shu-Ying</au><au>Naito, Makoto</au><au>Tachibana, Keisuke</au><au>Doi, Takefumi</au><au>Shulman, Andrew I.</au><au>Mangelsdorf, David J.</au><au>Reiter, Raphael</au><au>Auwerx, Johan</au><au>Hamakubo, Takao</au><au>Kodama, Tatsuhiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Generation of Monoclonal Antibodies against Human Peroxisome Proliferator-activated Receptors (PPARs)</atitle><jtitle>Journal of Atherosclerosis and Thrombosis</jtitle><addtitle>JAT</addtitle><date>2002</date><risdate>2002</risdate><volume>9</volume><issue>5</issue><spage>233</spage><epage>242</epage><pages>233-242</pages><issn>1340-3478</issn><eissn>1880-3873</eissn><abstract>Monoclonal antibodies (Mabs) are valuable reagents for the purification, characterization and immunolocalization of proteins. In this study, we raised Mabs against human peroxisome proliferator-activated receptors (PPARs) using baculovirus particles displaying surface glycoprotein gp64-fusion proteins as the immunizing agent. In this system, to display fusion proteins on the viral surface, the amino terminal sequences of human PPARδ and PPARγ2 are inserted in-frame between the signal sequence and the mature domain of the gp64 nucleotide sequence. Mabs were raised by immunization with whole virus without a purification of the target antigens. The Mabs generated by this novel method were shown to recognize not only the gp64-PPARs fusion protein, but also mature, expressed proteins by a wide variety of techniques, including immunohistochemistry, immunoblotting, and electrophoretic mobility shift assays (EMSAs). Transfection of the transfer vector containing a nucleotide sequence encoding less than 30 amino acids along with linearized baculovirus DNA allows for the production of a high affinity antibody against the corresponding mature form. This method is of potential utility in that it allows the production of valuable antibodies without the requirement of a protein purification step.</abstract><cop>Japan</cop><pub>Japan Atherosclerosis Society</pub><pmid>12409633</pmid><doi>10.5551/jat.9.233</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1340-3478
ispartof Journal of Atherosclerosis and Thrombosis, 2002, Vol.9(5), pp.233-242
issn 1340-3478
1880-3873
language eng
recordid cdi_hal_primary_oai_HAL_hal_04151318v1
source MEDLINE; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese; EZB-FREE-00999 freely available EZB journals
subjects Animals
Antibodies, Monoclonal - genetics
Antibodies, Monoclonal - immunology
Baculovirus
Blotting, Western
CHO Cells
Cricetinae
Electrophoretic Mobility Shift Assay
Enzyme-Linked Immunosorbent Assay
Female
Gp64-fusion protein
Humans
Immunohistochemistry
Life Sciences
Mice
Mice, Inbred BALB C
Monoclonal antibody (Mab)
Nucleopolyhedrovirus - genetics
Peroxisome proliferator-activated receptors (PPARs)
Receptors, Cytoplasmic and Nuclear - immunology
Recombinant Fusion Proteins - genetics
Recombinant Fusion Proteins - immunology
Spodoptera
Transcription Factors - immunology
title The Generation of Monoclonal Antibodies against Human Peroxisome Proliferator-activated Receptors (PPARs)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A32%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Generation%20of%20Monoclonal%20Antibodies%20against%20Human%20Peroxisome%20Proliferator-activated%20Receptors%20(PPARs)&rft.jtitle=Journal%20of%20Atherosclerosis%20and%20Thrombosis&rft.au=Tanaka,%20Toshiya&rft.date=2002&rft.volume=9&rft.issue=5&rft.spage=233&rft.epage=242&rft.pages=233-242&rft.issn=1340-3478&rft.eissn=1880-3873&rft_id=info:doi/10.5551/jat.9.233&rft_dat=%3Cproquest_hal_p%3E72644260%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72644260&rft_id=info:pmid/12409633&rfr_iscdi=true